Tsinghua university, MBA in MIT International
Shenyang Pharmaceutical University, BS
Rich industrial experience and investment experience, over 10 years of industrial experience, nearly eight years of investment experience, has accumulated partial experience of R & D, Production, BD, marketing and investment, and other multi-directional. Investment experience covers angel, VC, PE, preIPO, M & A integration, directional add-issuance and other full-phase projects.
Saike: Head of purification, bio division
Pfizer: Regional head of sales department
Walvax Biotechnology: Investment Project Manager
GTJA Investment Group: Partner
In 2001, participated in the pre-clinical pilot process development of antibody drugs and approval related work of new drug IND; led the purification part of the process to identify and declare related preparations; participated in M&A of 2 subsidiaries and post-investment integration management of listed companies; introduced strategic investors for the subsidiaries, increased of 500 million strategic capital, and promoted project fund-rising and sustainable development; In collaboration with Bill & Melinda Gates Foundation and William J.Clinton Foundation, analyzed the global demand for HPV vaccine and PCV13 vaccine and the opportunities and feasibility of domestic enterprises to participate; and implementation of the major assets reorganization projects of listed companies and non-listed companies.
Genor Biopharma Co. Ltd, Shanghai Zerun Biotechnology Co. Ltd, United imaging, Elpiscience, Ab&b Biotechnology Co. Ltd and etc.